Balentine LLC’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-898
Closed -$110K 928
2020
Q2
$110K Buy
898
+312
+53% +$36.1K 0.01% 140
2020
Q1
$60K Sell
586
-114
-16% -$15.1K ﹤0.01% 165
2019
Q4
$99K Sell
700
-5,318
-88% -$678K 0.01% 118
2019
Q3
$717K Buy
6,018
+13
+0.2% +$1.55K 0.04% 46
2019
Q2
$817K Hold
6,005
0.05% 38
2019
Q1
$851K Hold
6,005
0.06% 35
2018
Q4
$680K Buy
6,005
+5,305
+758% +$607K 0.05% 48
2018
Q3
$78K Buy
+700
New +$79.2K 0.01% 49
2018
Q1
Sell
-4,822
Closed -$536K 577
2017
Q4
$536K Hold
4,822
0.04% 58
2017
Q3
$482K Sell
4,822
-613
-11% -$62.9K 0.04% 57
2017
Q2
$561K Hold
5,435
0.05% 44
2017
Q1
$495K Buy
5,435
+3
+0.1% +$250 0.05% 48
2016
Q4
$428K Hold
5,432
0.05% 51
2016
Q3
$474K Buy
5,432
+5,227
+2,550% +$426K 0.07% 46
2016
Q2
$15K Buy
+205
New +$14.9K ﹤0.01% 286
2015
Q4
Sell
-1,004
Closed -$65K 486
2015
Q3
$65K Hold
1,004
0.01% 138
2015
Q2
$74K Sell
1,004
-273
-21% -$21.4K 0.01% 118
2015
Q1
$105K Buy
+1,277
New +$102K 0.02% 90

Other funds holding VAR

Balentine LLC's VAR Position: Q3 2020 in Review

Balentine LLC sold out of Varian Medical Systems, Inc. (VAR) in Q3 2020, closing a stake of 898 shares — an estimated $110K sold.

Balentine LLC first reported a position in VAR in Q1 2015 and held it in 18 quarters. The position peaked at $851K in Q1 2019. 642 funds tracked by Wall St. Rank hold VAR as of Q3 2020.

  • Balentine LLC reported no remaining Varian Medical Systems, Inc. position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 898 Varian Medical Systems, Inc. shares in Q3 2020, an estimated $110K.
  • Balentine LLC first reported a position in Varian Medical Systems, Inc. in Q1 2015 and held it in 18 quarters.
  • Balentine LLC's Varian Medical Systems, Inc. position peaked at $851K in Q1 2019.
  • 642 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.